hit counter

Twin Study Finds No Broad Cytokine Link to Depression or Alcohol Use Disorder

Photoreal illustration of cytokine molecules and brain imagery, conveying inflammation-depression hypothesis under scrutiny.

The broad cytokine story failed its most direct community test: in 972 adults, depression, alcohol use, and alcohol use disorder (AUD) were not associated with C-reactive protein (CRP) or a pre-registered pro-inflammatory cytokine index. The only multiple-testing-corrected cytokine hits ran opposite the hypothesis — AUD was linked to lower IL-1β, IL-4, IL-10, and IL-12 — …

Read more

TRD MRI Coupling Classified Depression Resistance Above 0.88 AUC

A 2026 multimodal MRI study found that treatment-resistant depression had lower coordination between brain structure and brain activity than non-treatment-resistant depression in frontal, parietal, motor, and temporal regions. Machine-learning models using those structure-function coupling measures classified treatment-resistant vs. non-treatment-resistant depression with AUC values from 0.886 to 0.950 in the primary atlas analysis.1 Research Highlights TRD …

Read more

Naltrexone Reduced Reappraisal Distress in 38-Person Threat fMRI Trial

Photoreal illustration of brain with vmPFC, amygdala, and threat-processing circuitry highlighted under pharmacological challenge.

The endogenous opioid system has been a candidate target for novel anxiety treatments, but a 2026 placebo-controlled crossover fMRI study in 38 healthy volunteers ran opposite the hypothesis: instead of increasing threat-related distress and amygdala reactivity, 50 mg oral naltrexone reduced subjective distress during cognitive reappraisal (p = 0.044, d = 0.57) and shifted ventromedial …

Read more

Subcallosal Cingulate DBS for Treatment-Resistant Depression

MHD featured image for Subcallosal Cingulate DBS for Treatment-Resistant Depression.

A 2026 systematic review of subcallosal cingulate (SCC) functional connectivity found 28 qualifying resting-state fMRI studies in depression: 21 rTMS/iTBS studies, 4 ECT studies, 3 focused-ultrasound studies, and 0 DBS or tDCS studies.1 That number is the useful correction: SCC DBS may still be biologically plausible, but the current fMRI connectivity literature mostly explains noninvasive …

Read more

Alpha-Synuclein SAA Predicts Parkinson’s Levodopa Response Durability

Photoreal illustration of CSF biomarker testing alongside dopaminergic neuron pathways, representing PD biomarker stratification.

A 2026 PPMI analysis found that Parkinson’s patients with positive CSF α-synuclein seed amplification assay results kept gaining levodopa benefit over follow-up, while SAA-negative patients showed faster ON-medication motor progression than SAA-positive patients: 0.87 vs. 3.47 MDS-UPDRS Part III points/year in 183 matched SAA-positive and 40 SAA-negative patients.1 Research Highlights ON-state progression split sharply: SAA-positive …

Read more

Leaded Gasoline and ALS: Australia’s MND Surge Tracks Lead

Photoreal illustration linking historical leaded-petrol exposure with motor neurone disease, with imagery of a vintage gas pump and motor neuron motifs.

A 2026 Australian ecological model found that 20-year-lagged cumulative population blood-lead burden was nonlinearly tied to motor neuron disease mortality (lead spline p = 0.00024), while national insecticide use did not independently explain the curve after adjustment (p = 0.39).1 That is a real lead signal, but it is still population-level evidence, not proof that …

Read more

Alzheimer’s RVI-AD MRI Score Predicted Dementia Conversion With 0.70 AUC

A 2026 Molecular Psychiatry study found that RVI-AD, a structural-MRI score measuring how closely a person’s brain anatomy matches an Alzheimer’s disease pattern, predicted mild-cognitive-impairment conversion to dementia most strongly over the next 3 years: OR 2.16, 95% CI 1.81-2.57, p < 2e-16, AUC 0.70.1 Research Highlights Short-term conversion signal: in 965 ADNI participants with …

Read more